ECOC — ABVC BIOPHARMA, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1173313 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2011 | 720 | 1,953,056 | -328,716 | 482,734 | 369,396 | 71,784 | 1,833,069 |
TTM Snapshot
Revenues TTM
$720
NetIncome TTM
$482,734
OpCashFlow TTM
$0
Assets (Latest)
$369,396
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.12T | $1255.40 | — |
| JNJ | JOHNSON & JOHNSON | $651.25B | $270.24 | — |
| ABBV | AbbVie Inc. | $468.22B | $264.96 | — |
| MRK | Merck & Co., Inc. | $376.37B | $152.55 | — |
| NVS | NOVARTIS AG | $301.95B | $158.86 | — |
Recent Insider Activity
No insider activity indexed for this ticker.